Main Article Content

Syahbuddin
Yusnita
Lisma Luciana
T. Khairul Rozi
Yulidar
Analia Husna

Page: 2523-2531

Abstract

Background: Rational medicine use is particularly important in older adults with rheumatoid arthritis (RA), who may face complex regimens, multimorbidity, and a greater risk of adverse drug events. Objective: To evaluate self-reported medication use and examine its associations with knowledge, adherence, and perceived clinical improvement among older adults with RA in Lameue Village, Pidie Regency. Methods: This cross-sectional correlational study included all 45 eligible older adults with RA in the study population (total sampling). Data were collected using a questionnaire reported as valid and reliable. Categorical variables were summarized as frequencies and percentages, and associations were explored using Pearson's chi-square test at a 5% significance level. Results: Medication-use evaluation was predominantly moderate (62.2%). Knowledge was poor in 40.0% of respondents; adherence was good in 35.6%, moderate in 28.9%, and poor in 35.6%. Perceived clinical improvement was moderate in 53.3%. Knowledge (p=0.002), adherence (p=0.024), and perceived clinical improvement (p<0.001) were associated with medication-use evaluation. Several expected cell counts were below five; therefore, the results should be interpreted as exploratory. Conclusion: Knowledge and adherence were associated with better self-reported medication-use evaluation. Structured education, caregiver involvement, medication review, and follow-up may support safer medicine use, but causal and clinical effectiveness claims require confirmation using validated outcomes and robust analyses.

Downloads

Download data is not yet available.

Article Details

How to Cite
Syahbuddin , S., Yusnita, Y., Luciana , L., Rozi , T. K., Yulidar, Y., & Husna , A. (2026). Medication-Use Evaluation among Older Adults with Rheumatoid Arthritis in Lameue Village. Journal of Pharmaceutical and Sciences, 9(3), 2523–2531. https://doi.org/10.36490/journal-jps.com.v9i3.1776
Section
Original Articles

References

World Health Organization. Rheumatoid arthritis [Internet]. Geneva: WHO; 2023 [cited 2026 Aug 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/rheumatoid-arthritis

Zou W, Xiao Z, Wen X, et al. Increasing global burden of rheumatoid arthritis: an epidemiological analysis from 1990 to 2019. Arch Med Sci. 2023;19(6):1707-1716. doi:10.5114/aoms/162629.

Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3-18. doi:10.1136/ard-2022-223356.

Suryana BPP, Hidayat R, Sarmidi S, et al. Characteristics and prevalence of clinical remission of rheumatoid arthritis in a nationwide study from Indonesia. Int J Rheum Dis. 2024;27(2):e15050. doi:10.1111/1756-185X.15050.

Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-150. doi:10.14336/AD.2017.0306.

Erdem Sultanoğlu T. Medication adherence to pharmacological treatment and health literacy in patients with rheumatoid arthritis. Hosp Pract Res. 2024;9(2):456-461. doi:10.30491/hpr.2024.462336.1433.

Aksoy N, Ozturk N, Agh T, Kardas P. Adherence to antirheumatic drugs: a systematic review and meta-analysis. Front Med (Lausanne). 2024;11:1456251. doi:10.3389/fmed.2024.1456251.

Gorter A, Bakker MM, ten Klooster PM, et al. The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis. Rheumatology (Oxford). 2023;62(10):3409-3415. doi:10.1093/rheumatology/kead052.

Asgari S, Abbasi M, Hamilton K, et al. A theory-based intervention to promote medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Clin Rheumatol. 2021;40(1):101-111. doi:10.1007/s10067-020-05224-y.

Jinno S, Onishi A, Hattori S, et al. Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis: the ANSWER cohort study. Rheumatology (Oxford). 2025;64(2):509-516. doi:10.1093/rheumatology/keae081.

Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. doi:10.1002/art.27584.

Dey M, Budhathoki S, Elwell H, et al. Association of health literacy with disease outcomes in inflammatory arthritis: a systematic review. Ann Rheum Dis. 2025; published online Sep 11. doi:10.1016/j.ard.2025.08.018.

Truijen SPM, Schreurs JPR, Boonen A, van Onna M. The operational definition of old age and impact on outcomes in DMARD-treated patients with rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2025;71:152607. doi:10.1016/j.semarthrit.2024.152607.

Smith ID, England BR, Pagidipati NJ, Bosworth H. Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. veterans. Expert Rev Pharmacoecon Outcomes Res. 2025;25(4):473-485. doi:10.1080/14737167.2025.2451141.

Ahijón Lana M, Sivera Mascaró F, Fernández-Nebro A, et al. EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis. RMD Open. 2025;11(1):e004989. doi:10.1136/rmdopen-2024-004989.

Nikiphorou E, Santos EJF, Marques A, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis. 2021;80(10):1278-1285. doi:10.1136/annrheumdis-2021-220249.

Marques A, Santos E, Nikiphorou E, Bosworth A, Carmona L. Effectiveness of self-management interventions in inflammatory arthritis: a systematic review informing the 2021 EULAR recommendations. RMD Open. 2021;7(2):e001647. doi:10.1136/rmdopen-2021-001647.

Gwinnutt JM, Wieczorek M, Balanescu A, et al. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2023;82(1):48-56. doi:10.1136/annrheumdis-2021-222020.

Nagy G, Roodenrijs NMT, Welsing PMJ, et al. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis. 2022;81(1):20-33. doi:10.1136/annrheumdis-2021-220973.

Lois P, López Pedraza L, Rodero M, et al. Emerging trends in nurse-led programs of care for management of patients with established rheumatoid arthritis: systematic literature review. Reumatol Clin (Engl Ed). 2023;19(10):579-592. doi:10.1016/j.reumae.2023.10.004.

Yajima N, Kawaguchi T, Takahashi R, et al. Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study. BMC Rheumatol. 2022;6:75. doi:10.1186/s41927-022-00305-8.

Huang L, Zhou Y, Liu Y, Xu P, Deng X. Medication adherence and illness perception in patients with rheumatoid arthritis: the mediating effect of self-efficacy. J Musculoskelet Neuronal Interact. 2025;25(1):101-108. doi:10.22540/JMNI-25-101.